Ensayos clínicos

Lymphangioleiomyomatosis

Displaying 1 study

  • Safety and Durability of Sirolimus for Treatment of LAM Jacksonville, FL; Rochester, MN

    The MIDAS study aims to follow women with LAM who are currently taking, have previously failed or been intolerant of, or are considering treatment with mTOR inhibitors sirolimus or everolimus as part of their clinical care.

.

Mayo Clinic Footer